Natera Executives Sell Shares Amid Recent Decline in Stock Price

Natera, Inc. (NTRA) has announced that Michael Burkes, Chief Financial Officer, sold 700 shares at $225.25 per share on February 3, 2026, and also sold 4,971 shares at $227.45 per share on the same day. Additionally, he sold 1,268 shares at $230.77 per share on February 3, 2026. Steven Leonard Chapman, Director, CEO, and President, sold 7,445 shares at $233.31 per share on February 2, 2026, as well as 9,197 shares at $232.41 per share on the same day. He also sold 20,079 shares at $230.95 per share on February 2, 2026, and 6,631 shares at $229.08 per share on February 2, 2026. Furthermore, he sold 41,847 shares at $230.03 per share on February 2, 2026, and 4,725 shares at $230.77 per share on February 3, 2026. He also sold 100 shares at $234 per share on February 2, 2026. John Fesko, President and Chief Business Officer, sold 2,415 shares at $231.14 per share on February 3, 2026, and 1,179 shares at $230.77 per share on the same day. Solomon Moshkevich, President of Clinical Diagnostics, sold 1,639 shares at $230.77 per share on February 3, 2026, and 600 shares at $233.24 per share on February 2, 2026. He also sold 850 shares at $232.33 per share on February 2, 2026, and 576 shares at $230.84 per share on the same day. Additionally, he sold 878 shares at $229.96 per share on February 2, 2026, and 80 shares at $228.50 per share on the same day. He also sold 16 shares at $234 per share on February 2, 2026. Daniel Rabinowitz, Secretary and Chief Legal Officer, sold 1,334 shares at $230.77 per share on February 3, 2026. Sheena Jonathan, Director and Other, sold 435 shares at $230.77 per share on February 3, 2026.